Literature DB >> 22182275

Bypass for the prevention of ischemic stroke.

Ana Rodríguez-Hernández1, S Andrew Josephson, Andrew S Josephson, David Langer, Michael T Lawton.   

Abstract

OBJECTIVE: Although most ischemic strokes are thromboembolic in origin and their management is endovascular or medical, some are hemodynamic in origin and their management may be surgical. Extracranial-intracranial bypass with superficial temporal artery-to-middle cerebral artery (MCA) bypass, high-flow interposition grafts, and reconstructive techniques have been developed. Clinical indications and efficacy are controversial, and this review examines current practices.
METHODS: Bypass surgery is indicated for patients with athero-occlusive disease that results in chronic, low cerebral blood flow accompanied by episodes of ischemic symptoms. Specific diagnoses include: (1) internal carotid artery occlusion; (2) MCA occlusion and, rarely, high-grade MCA stenosis; (3) vertebrobasilar atherosclerotic steno-occlusive disease; (4) vasculitis resulting in severe occlusive disease; and (5) moyamoya disease.
RESULTS: Discouraging results from the Extracranial-Intracranial Bypass Trial demonstrated the importance of selecting surgical patients based on objective measures of hemodynamic insufficiency. Two such tests are xenon-enhanced computed tomography with acetazolamide challenge and positron emission tomography with measurement of oxygen extraction fraction. Perfusion computed tomography may be another, more practical test. Surgical series, systematic reviews of the literature, and two new randomized clinical trials that use these diagnostic techniques reveal contradictory results. Although they demonstrate that bypass surgery has a morbidity rate of less than 5% and a patency rate of more than 95%, they have not proven a clear benefit.
CONCLUSIONS: Patients with athero-occlusive disease and symptoms of hemodynamic insufficiency have significant risk of stroke if left untreated or managed medically. On the other hand, surgical intervention lacks supporting evidence. Clinicians must individualize their management recommendations until additional data are published or further consensus develops.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22182275     DOI: 10.1016/j.wneu.2011.06.032

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

Review 1.  Collaterals: Implications in cerebral ischemic diseases and therapeutic interventions.

Authors:  Yasuo Nishijima; Yosuke Akamatsu; Phillip R Weinstein; Jialing Liu
Journal:  Brain Res       Date:  2015-03-11       Impact factor: 3.252

2.  Changes in computed tomography perfusion parameters after superficial temporal artery to middle cerebral artery bypass: an analysis of 29 cases.

Authors:  Joseph C Serrone; Lincoln Jimenez; Dennis J Hanseman; Christopher P Carroll; Aaron W Grossman; Lily Wang; Achala Vagal; Ondrej Choutka; Norberto Andaluz; Andrew J Ringer; Todd Abruzzo; Mario Zuccarello
Journal:  J Neurol Surg B Skull Base       Date:  2014-05-27

3.  The outcome and efficacy of recanalization in patients with acute internal carotid artery occlusion.

Authors:  J H Kwak; L Zhao; J K Kim; S Park; D-G Lee; J H Shim; D H Lee; J S Kim; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2013-10-03       Impact factor: 3.825

4.  Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke.

Authors:  Xue-Feng Fu; Xin Zhang; Dong-Jun Wang; Bo Zhao; Yu-Rong Li
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

5.  Zigzag skin incision effectively camouflages the scar and alopecia for moyamoya disease: technical note.

Authors:  Yasuhiro Sanada; Tomonari Yabuuchi; Hiromasa Yoshioka; Hisashi Kubota; Amami Kato
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

6.  Preservation of spatial memory and neuroprotection by the fatty acid amide hydrolase inhibitor URB597 in a rat model of vascular dementia.

Authors:  Da-Peng Wang; Qi Lin; Kai Kang; Yi-Fang Wu; Shao-Hua Su; Jian Hai
Journal:  Ann Transl Med       Date:  2021-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.